Our Vaccine Technology

 There are two components in this technology: 1) Defining the immune-relevant epitopes and 2) Targeting the combination of those epitopes to the immune system to elicit a specific immune response. In the first component, we go through a series of iterative steps in which vaccine candidates are progressively defined. We use or develop an experimental challenge model to test the efficacy of the vaccine every step of the way. We then select a proper vaccine targeting method to achieve appropriate protection.